Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, molds, animal proteins, foods, medications, etc. When an allergic individual comes in contact with an allergen, the immune system mounts a response through the IgE antibody. People who are prone to allergies are called as allergic or "atopic." The allergic symptoms may include runny nose, sneezing, blocked sinuses, itching, watery eyes, etc. An allergy diagnostic test may involve either a skin test or a blood test which helps to diagnose particular pollens, molds, or other allergens a particular person is allergic to. Once the allergen is determined, doctors may come up with a plan for avoiding those allergens and can also prescribe medications to ease the symptoms.
Market - Headwinds & Tailwinds
The global allergy diagnostics market is mainly driven by rising incidence of allergies across the globe, growing adoption of advanced allergy diagnostics kits & technology and increasing environmental pollution. Favorable reimbursement scenario in the U.S. is also playing a pivotal role in contributing to the growth of the market globally. However, lack of coverage for the test in emerging countries and issues related to affordability of allergy diagnostics instruments are likely to restrain the market growth to a certain extent.
The global allergy diagnostics market has been analyzed from five perspectives: Test Type, Product Type, Allergan Type, End User and Region.
Based on test type, the allergy diagnostics market has been segmented into in vivo and in vitro. The in vivo tests include test, such as prick and intradermal skin tests, whereas, in vitro tests include tests such as RAST, MAST, FAST, ELISA, and ImmunoCAP. The in vivo segment holds the largest share in the market. The growth of the segment can be attributed to rising adoption of the test by healthcare professionals and patients due to its benefits such as ease of use, wider availability, and favorable reimbursement policies.
Based on product type, the allergy diagnostics market has been segmented into instruments, consumables and services. The consumables segment holds the largest share in the market. Consumable’s segment consists of the kits, reagents and other components of allergy diagnostics. The growth of the segment can be attributed to easy accessibility of diagnostic kits and their frequent purchase for each test performed as compared to the one-time purchase of instruments.
Based on allergen type, the market has been segmented into drug allergens, inhaled allergens, food allergens and others. The food allergens segment is expected to be the fastest growing segment during the forecast period owing to growing prevalence of food allergies especially in children. Researchers estimate that around 32 million Americans have food allergies, including 5.6 million children under the age of 18. According to FARE (Food Allergy Research & Education), each year around 200,000 people in the U.S. require emergency medical care for allergic reactions to food.
Based on end user, the allergy diagnostics market has been segmented into hospitals, diagnostic laboratories, academic research institutes and others. The diagnostic laboratories segment holds the largest share in the market. The growth of the market can be attributed to availability of advanced diagnostic kits & technology and increasing number of immunoassay tests performed for allergy diagnostics.
Based on region, the global allergy diagnostics market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the allergy diagnostics market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to its well-developed healthcare facilities, growing prevalence of various type of allergies, increasing adoption of highly advanced allergy diagnostics, favorable reimbursement scenario and presence of prominent players in the region.
The allergy diagnostics market is marked by presence of prominent players such as Siemens Healthcare Private Limited, Thermo Fisher Scientific, bioMérieux SA, Hitachi Chemical Diagnostics, Inc., Omega Diagnostics Group PLC, StatNano, HYCOR Biomedical, Lincoln Diagnostics, Inc., Stallergenes Greer and HOB Biotech Group Corp., Ltd. Other players operating in the market are R-Biopharm AG, Alcon, among others.
• In Apr 2021, Mayo Clinic, a nonprofit organization committed to innovation in clinical practice, education & research, and Thermo Fisher Scientific joined forces to bring innovative solutions to patients by accelerating clinical validation, and commercialization of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. The collaborative effort will leverage NGS, mass spectrometry and immunology technologies to advance hematology, oncology, allergy and autoimmunity diagnostics
• In Feb 2021, The Food Allergy Science Initiative (FASI) announced it beginning as a separate, independent organization dedicated to discovering the root causes of food allergies through rigorous scientific research and deploying new therapies to treat and ultimately cure them
• In Jun 2020, AllerGenis LLC, a data-driven precision diagnostics company focused on food allergies, announced the onset of operations at its Hatfield facility to test patient samples using its VeriMAPTM Peanut Diagnostic, a diagnostic solution for patients with peanut allergies
• In Jan 2020, AllerGenis, LLC announced that it has entered into a non-exclusive agreement with Luminex Corporation. According to the terms of the agreement, AllerGenis will have the rights to develop, market and sell its novel precision food allergy diagnostic assay using Luminex’s xMAP® Technology
• In Jan 2019, AllerGenis announced a non-exclusive deal with Luminex for use of the company's xMAP technology to develop, market, and sell a precision food allergy diagnostic assay
• In Dec 2018, Hycor Biomedical, a manufacturer of in vitro diagnostic products for allergy and autoimmune testing, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new allergy testing system, NOVEOS
• Quantitative (market size and forecasts) and qualitative insights of the market across years - historical years, current year and forecasted years
• Deep-rooted insights on headwinds, tailwinds and opportunities prevailing in the market
• Quantitative (market size and forecasts) and qualitative insights at segment and sub-segment level
• Comprehensive quantitative (market size and forecasts) and qualitative insights on geographic, regional and country level markets
• Granular insights on the competitive landscape prevailing in the market
• Competitive mapping of strategic developments
|Market Size Period||2018-2031|
|Market Segments||Asessment of Allergy Diagnostics Market By:
• Test Type
• Product Type
• Allergen Type
|Geographic Scope||• North America
◦ Rest of Europe (RoE)
• Asia Pacific
◦ Rest of Asia Pacific (RoAPAC)
• Rest of the World
◦ Latin America
◦ Middle East & Africa
|Companies Covered||Siemens Healthcare Private Limited, Thermo Fisher Scientific, bioMérieux SA, Hitachi Chemical Diagnostics, Inc., Omega Diagnostics Group PLC, StatNano, HYCOR Biomedical, Lincoln Diagnostics, Inc., Stallergenes Greer and HOB Biotech Group Corp., Ltd., R-Biopharm AG, Alcon, among others.|
1 RESEARCH ENVELOPE
1.1 Market Classification
1.2 Scope of the Study
1.2.1 Timeline Considered for Market Study
· Historic Years – 2018 & 2019
· Base Year – 2020
· Projected Years – 2021 to 2031
1.3 Currency Used in the Report
2 RESEARCH METHODOLOGY
2.1 Research Approach
2.2 Data Collection Methodology
2.3 Data Sources
2.3.1 Secondary Sources
2.3.2 Primary Sources
2.4 Market Crackdown Methodology
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Forecasting Model
2.6 Limitations and Assumptions for Study
3 HEADWINDS & TAILWINDS ASSESSMENT
4 MARKET OPPORTUNITIES ASSESSMENT
5 PREMIUM INSIGHTS
5.1 Key Market Trends
5.2 Key Players & Their Competitive Positioning (2020)
5.3 COVID-19 Impact Assessment
6 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY TEST TYPE
6.1 In Vivo
6.2 In Vitro
7 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
7.1.1 ELISA Analyzers
7.1.3 Other Instruments
8 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY ALLERGEN TYPE
8.1 Drug Allergens
8.2 Inhaled Allergens
8.3 Food Allergens
9 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY END USER
9.2 Diagnostic Laboratories
9.3 Academic Research Institutes
10 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY REGION
10.1 North America Allergy Diagnostics Market
10.1.1 North America Allergy Diagnostics Market, By Country
10.1.2 North America Allergy Diagnostics Market, By Test Type
10.1.3 North America Allergy Diagnostics Market, By Product Type
10.1.4 North America Allergy Diagnostics Market, By Allergen Type
10.1.5 North America Allergy Diagnostics Market, By End User
10.2 Europe Allergy Diagnostics Market
10.2.1 Europe Allergy Diagnostics Market, By Country/Region
10.2.1.4 Rest of Europe (ROE)
10.2.2 Europe Allergy Diagnostics Market, By Test Type
10.2.3 Europe Allergy Diagnostics Market, By Product Type
10.2.4 Europe Allergy Diagnostics Market, By Allergen Type
10.2.5 Europe Allergy Diagnostics Market, By End User
10.3 Asia Pacific Allergy Diagnostics Market
10.3.1 Asia Pacific Allergy Diagnostics Market, By Country/Region
10.3.1.4 Rest of Asia Pacific (RoAPAC)
10.3.2 Asia Pacific Allergy Diagnostics Market, By Test Type
10.3.3 Asia Pacific Allergy Diagnostics Market, By Product Type
10.3.4 Asia Pacific Allergy Diagnostics Market, By Allergen Type
10.3.5 Asia Pacific Allergy Diagnostics Market, By End User
10.4 Rest of the World (RoW) Allergy Diagnostics Market
10.4.1 Rest of the World Allergy Diagnostics Market, By Region
10.4.1.1 Latin America
10.4.1.2 Middle East & Africa
10.4.2 Rest of The World Allergy Diagnostics Market, By Test Type
10.4.3 Rest of The World Allergy Diagnostics Market, By Product Type
10.4.4 Rest of The World Allergy Diagnostics Market, By Allergen Type
10.4.5 Rest of The World Allergy Diagnostics Market, By End User
11 COMPANY PROFILES
11.1 Siemens Healthcare Private Limited
11.1.1 Business Overview
11.1.2 Financial Metrics*
11.1.3 Product & Services Portfolio
11.1.4 Key Developments
11.2 Thermo Fisher Scientific
11.3 bioMérieux SA
11.4 Hitachi Chemical Diagnostics, Inc.
11.5 Omega Diagnostics Group PLC
11.7 HYCOR Biomedical
11.8 Lincoln Diagnostics, Inc.
11.9 Stallergenes Greer
11.10 HOB Biotech Group Corp., Ltd
*Insights on financial metrics is subject to availability of information in the public domain
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...
A contract research organization (CRO) also known as a clinical research organization, is an organization that provides services to pharmaceutical, biotechnology, and medical device companies.
Cell and gene therapy (CGT) companies partner with CGT CDMOs to get support on discovery, preclinical, clinical stages, CGT product development, manufacturing, and commercial manufacturing.
Contract Research, Development and Manufacturing (CRDMO) provides a fully integrated suite of end-to-end solutions for discovery, development, and manufacturing to meet all future market demands.